Ventive Hospitality Limited

Serum Institute of India newly bought 2,401,379 shares of Ventive Hospitality Limited, a 1.03% stake worth ₹149.38 crore at ₹622.15 apiece.

An owner, developer, and asset manager of luxury and business hotels and resorts across India, Ventive Hospitality operates premium properties catering to corporate and leisure travelers. The company develops and manages branded hotel assets while maintaining operational control across its portfolio. Since its incorporation in 2002, it has established itself as a significant player in India's upscale hospitality sector, with expertise in property development and long-term asset management.

World's largest vaccine manufacturer by volume, producing over 1.5 billion doses a year and reaching an estimated 65% of the world's children with at least one of its vaccines. Standalone revenue of Rs 10,900 crore in FY25. The Poonawalla family deploys surplus cash flow into Indian listed equities across pharma, financial services and consumer names, with Adar Poonawalla personally tracked as one of India's most aggressive private investors.